Clomiphene as a novel modality for the treatment of acute myeloid leukemia: A pilot phase II study

Leukemia Research

Volumn 36, Issue 1, 2012, Pages 42-45

  Yom Tov, G ^a   Nathan, I ^a   Shpilberg, O ^a   Polliack, A ^b   Levi, I ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

AML; Clinical study; Clomiphene

Indexed keywords

CLOMIFENE; CYTARABINE; ETOPOSIDE; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE DURATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PILOT STUDY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RECURRENT CANCER; SURVIVAL TIME; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; CLOMIPHENE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PILOT PROJECTS; RECURRENCE; SALVAGE THERAPY; SURVIVAL ANALYSIS; THERAPIES, INVESTIGATIONAL;

EID: 83555168180     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.08.015     Document Type: Article

References (8)

1. Mandelkar S., Kong A.N. Mechanisms of tamoxifen-induced apoptosis. Apoptosis 2001, 6:469-477.
2. Lens M.B., Reiman T., Husain A.F. Use of tamoxifen in the treatment of malignant melanoma. Cancer 2003, 98:1355-1361.
3. Geldmann E.P. Tamoxifen for the treatment of malignancies other than breast and endometrial carcinoma. Semin Oncol 1997, 24. S1-65-S1-70.
4. Steven P.T., Gerrard T., Mitsuyoshi U., Abushi O., Dharminder C.H., Webb I.Y., et al. Antiestrogens induced apoptosis of multiple myeloma cells. Blood 1998, 92:1749-1757.
5. Hayon T., Dvilansky A., Oriev L., Nathan I. Non-steroidal antiestrogens induce apoptosis in HL60 and MOLT3 leukemic cells: involvement of reactive oxygen radicals and protein kinase C. Anticancer Res 1999, 19:2089-2094.
6. Hayon T., Atlas L., Levy E., Dvilansky A., Shpilberg O., Nathan I. Multifactorial activities of nonsteroidal antiestrogens against leukemia. Cancer Detect Prev 2003, 27(5):389-396.
7. de Medina P, Paillasse MR, Ségala G, Khallouki F, Brillouet S, Dalenc F, et al. Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands. Chem Phys Lipids; in press.
8. Burnett A.K., Milligan D., Prentice A.G., Goldstone A.H., McMullin M.F., Hills R.K., et al. A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment. Cancer 2007, 109(6):1114-1124.